{"id":"https://openalex.org/W84343737","doi":null,"title":"Adapalene-benzoyl peroxide once-daily, fixed-dose combination gel for the treatment of acne vulgaris: a randomized, bilateral (split-face), dose-assessment study of cutaneous tolerability in healthy participants.","display_name":"Adapalene-benzoyl peroxide once-daily, fixed-dose combination gel for the treatment of acne vulgaris: a randomized, bilateral (split-face), dose-assessment study of cutaneous tolerability in healthy participants.","publication_year":2008,"publication_date":"2008-03-01","ids":{"openalex":"https://openalex.org/W84343737","mag":"84343737","pmid":"https://pubmed.ncbi.nlm.nih.gov/18441854"},"language":"en","primary_location":{"id":"pmid:18441854","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18441854","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cutis","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5068989339","display_name":"Philippe Andr\u00e8s","orcid":"https://orcid.org/0000-0003-4706-8099","observed_orcids":["https://orcid.org/0000-0003-4706-8099"]},"institutions":[{"id":"https://openalex.org/I4210120458","display_name":"Galderma (France)","ror":"https://ror.org/034kxvk28","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210120458","https://openalex.org/I4210163806"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Philippe Andres","raw_affiliation_strings":["Galderma Research and Development, Sophia Antipolis, France. philippe.andres@galderma.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Galderma Research and Development, Sophia Antipolis, France. philippe.andres@galderma.com","institution_ids":["https://openalex.org/I4210120458"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044699092","display_name":"Colette Pernin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Colette Pernin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"Michel Poncet","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michel Poncet","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":3.7901,"has_fulltext":false,"cited_by_count":23,"citation_normalized_percentile":{"value":0.92314949,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"81","issue":"3","first_page":"278","last_page":"84"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11553","display_name":"Acne and Rosacea Treatments and Effects","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11553","display_name":"Acne and Rosacea Treatments and Effects","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11013","display_name":"Skin Protection and Aging","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acne-vulgaris","display_name":"acne","score":0.8679999709129333},{"id":"https://openalex.org/keywords/adapalene","display_name":"adapalene","score":0.9779999852180481},{"id":"https://openalex.org/keywords/benzoyl-peroxide","display_name":"benzoyl peroxide","score":1.0},{"id":"https://openalex.org/keywords/fixed-dose-combination","display_name":"fixed-dose combination","score":0.7879999876022339},{"id":"https://openalex.org/keywords/topical-retinoids","display_name":"topical retinoids","score":0.9300000071525574},{"id":"https://openalex.org/keywords/skin-irritation","display_name":"skin irritation","score":0.8330000042915344},{"id":"https://openalex.org/keywords/monotherapy","display_name":"monotherapy","score":0.47600001096725464}],"concepts":[{"id":"https://openalex.org/C2777140388","wikidata":"https://www.wikidata.org/wiki/Q352348","display_name":"Adapalene","level":5,"score":0.9590162038803101},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.9355583190917969},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8623178005218506},{"id":"https://openalex.org/C2778885487","wikidata":"https://www.wikidata.org/wiki/Q411424","display_name":"Benzoyl peroxide","level":4,"score":0.8511796593666077},{"id":"https://openalex.org/C2777673923","wikidata":"https://www.wikidata.org/wiki/Q79928","display_name":"Acne","level":2,"score":0.7373040914535522},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.7123627066612244},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.689919650554657},{"id":"https://openalex.org/C2776623344","wikidata":"https://www.wikidata.org/wiki/Q5456317","display_name":"Fixed-dose combination","level":2,"score":0.6306567192077637},{"id":"https://openalex.org/C2779121184","wikidata":"https://www.wikidata.org/wiki/Q1166142","display_name":"Erythema","level":2,"score":0.5698858499526978},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4856771230697632},{"id":"https://openalex.org/C2777063393","wikidata":"https://www.wikidata.org/wiki/Q77776","display_name":"Irritation","level":2,"score":0.475187212228775},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4203490912914276},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2762971520423889},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.0},{"id":"https://openalex.org/C521977710","wikidata":"https://www.wikidata.org/wiki/Q81163","display_name":"Polymer","level":2,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C44228677","wikidata":"https://www.wikidata.org/wiki/Q181898","display_name":"Polymerization","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000068816","descriptor_name":"Adapalene","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000152","descriptor_name":"Acne Vulgaris","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001585","descriptor_name":"Benzoyl Peroxide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D001585","descriptor_name":"Benzoyl Peroxide","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D001585","descriptor_name":"Benzoyl Peroxide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003879","descriptor_name":"Dermatologic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003879","descriptor_name":"Dermatologic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D003879","descriptor_name":"Dermatologic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004338","descriptor_name":"Drug Combinations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005145","descriptor_name":"Face","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009281","descriptor_name":"Naphthalenes","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D009281","descriptor_name":"Naphthalenes","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D009281","descriptor_name":"Naphthalenes","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:18441854","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18441854","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cutis","raw_type":"Journal Article"},{"id":"mag:84343737","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18441854","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1890819019","https://openalex.org/W2170428123","https://openalex.org/W2105610837","https://openalex.org/W7096067536","https://openalex.org/W49852758","https://openalex.org/W4253833206","https://openalex.org/W2770566202","https://openalex.org/W2900218295","https://openalex.org/W4240789505","https://openalex.org/W4234113793"],"abstract_inverted_index":{"Combination":[0],"therapy":[1],"is":[2],"an":[3],"effective":[4],"approach":[5],"to":[6,83,177,225],"simultaneously":[7],"target":[8],"multiple":[9],"pathogenic":[10],"factors":[11],"of":[12,20,63,72,85,133,160],"acne.":[13],"International":[14],"consensus":[15],"guidelines":[16],"recommend":[17],"the":[18,60,86,161,170,209,218],"use":[19],"topical":[21],"retinoids":[22],"and":[23,117,152,175],"benzoyl":[24],"peroxide":[25],"(BPO)":[26],"for":[27],"acne":[28],"treatment.":[29],"These":[30],"drugs":[31],"are":[32],"often":[33],"prescribed":[34],"as":[35],"a":[36],"free":[37],"combination":[38,67,93,102,111,121,165,171,184,215],"without":[39],"any":[40],"safety":[41],"concern":[42],"associated":[43],"with":[44,172,186],"antibiotic":[45],"use.":[46],"A":[47],"3-week,":[48],"randomized,":[49],"controlled,":[50],"investigator-blinded,":[51],"single-center,":[52],"bilateral":[53],"(split-face),":[54],"dose-assessment":[55],"study":[56],"was":[57,167],"conducted":[58],"comparing":[59],"cutaneous":[61,157,221],"tolerability":[62,158,222],"2":[64],"adapalene-BPO":[65],"fixed-dose":[66,211],"products":[68],"versus":[69,95,104,113,123],"various":[70],"concentrations":[71],"BPO":[73,96,105,114,124,173,178,187,194,201,226],"monotherapy":[74,196,203],"applied":[75],"once":[76],"daily.":[77],"Sixty":[78],"healthy":[79],"participants":[80],"were":[81],"randomized":[82],"one":[84],"following":[87],"treatment":[88],"groups:":[89],"adapalene":[90,99,108,118,162,212],"0.1%-BPO":[91,100,109,119,163,213],"2.5%":[92,97,101,164,179,214],"product":[94,103,112,122,166,185,216],"monotherapy;":[98,107,116],"5%":[106,110,115,120,174,181,188,195],"10%":[125,202],"monotherapy.":[126,182,227],"Assessments":[127],"included":[128],"total":[129],"sum":[130],"score":[131],"(TSS)":[132],"irritation":[134,148,192],"signs/":[135],"symptoms":[136],"(erythema,":[137],"scaling/desquamation,":[138],"dryness,":[139],"pruritus,":[140],"stinging/burning)":[141],"averaged":[142],"over":[143],"all":[144],"postbaseline":[145],"visits,":[146],"individual":[147],"signs/symptoms":[149],"(worst":[150],"score),":[151],"adverse":[153],"events.":[154],"The":[155,183],"overall":[156,220],"profile":[159,223],"better":[168],"than":[169,193],"similar":[176],"or":[180,200],"induced":[189],"significantly":[190],"more":[191],"(P":[197,204],"<":[198],".001)":[199],"=":[205],".001).":[206],"In":[207],"conclusion,":[208],"new":[210],"provided":[217],"best":[219],"relative":[224]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}